Cargando…

IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression

The interaction between tumor cells and stromal cells within the tumor microenvironment plays a critical role in cancer progression. Mesenchymal stem cells (MSCs) are important tumor stromal cells that exhibit pro-oncogenic activities when reprogrammed by the tumor. However, the precise mechanisms u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Runbi, Wu, Chenxi, Yao, Jun, Xu, Jiajin, Lin, Jiang, Gu, Hongbing, Fu, Min, Zhang, Xiaoxin, Li, Yongkang, Zhang, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590395/ https://www.ncbi.nlm.nih.gov/pubmed/37865637 http://dx.doi.org/10.1038/s41419-023-06163-7

Ejemplares similares

IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway
por: Chan, Leong-Perng, et al.
Publicado: (2016)

The recent advances of cancer associated fibroblasts in cancer progression and therapy
por: Wu, Chenxi, et al.
Publicado: (2022)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3
por: Wang, Saifeng, et al.
Publicado: (2019)

Betulin Targets Lipin1/2-Meidated P2X7 Receptor as a Therapeutic Approach to Attenuate Lipid Accumulation and Metaflammation
por: Dou, Jia-Yi, et al.
Publicado: (2022)

IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells
por: He, Qing, et al.
Publicado: (2022)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

Matrix metalloproteinase‐1 facilitates MSC migration via cleavage of IGF‐2/IGFBP2 complex
por: Guan, Shou P., et al.
Publicado: (2017)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis
por: Yang, Juze, et al.
Publicado: (2022)

m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
por: Qian, Benheng, et al.
Publicado: (2021)

IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification
por: Li, Simeng, et al.
Publicado: (2023)

IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
por: Wang, Xiangpu, et al.
Publicado: (2022)

Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway
por: Mao, Yan, et al.
Publicado: (2023)

Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism
por: Ni, Wei‐Jian, et al.
Publicado: (2023)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
por: Duesing, Konsta, et al.
Publicado: (2008)

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression
por: Wang, Cuicui, et al.
Publicado: (2022)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3
por: Yi, Jianmei, et al.
Publicado: (2023)

MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
por: Shi, Wenjing, et al.
Publicado: (2022)

Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer
por: Sun, Xin, et al.
Publicado: (2023)

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
por: Chen, Jinhao, et al.
Publicado: (2023)

Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes
por: Nfor, Oswald Ndi, et al.
Publicado: (2020)

m(6)A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
por: Wei, Huamei, et al.
Publicado: (2023)

IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016)

m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
por: Pu, Jian, et al.
Publicado: (2020)

MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1
por: Wang, Ping, et al.
Publicado: (2018)

MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1
por: Wang, Ping, et al.
Publicado: (2022)

IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma
por: Xu, Yun, et al.
Publicado: (2021)

HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification
por: Wang, Jiayu, et al.
Publicado: (2023)

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
por: Zhang, Meiling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2u6g4ncibv9dmcvhbjv4b52phg